A randomized, double-blind, placebo-controlled, multicenter, parallel-group, detrmination-range dose of MK-0633 performed in adult patients with COPD. MK 633-007 view Grant

status

  • Finished

date/time interval

  • 2008/01/02  To  2009/01/01